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1.3.2	Ghrelin	alters	encoding-related	brain	activity	without	enhancing	memory	formation	
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6.4.5	fMRI	data	acquisition		Whole-brain	 functional	 images	were	acquired	on	a	3T	 (GE	Discovery	MR750)	 scanner	using	a	2D	gradient	echo	planar	image	sequence.	For	both	the	task	and	the	resting	state	scans	we	used	a	repetition	time	(TR)	of	2.5	s,	an	echo	time	(TE)	of	30	ms	and	a	flip	angle	of	90°.	For	the	resting	state	scans	we	acquired	34	interleaved	slices	with	a	field	of	view	
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6.5	Results		In	contrast	 to	our	hypotheses	and	a	body	of	animal	research,	we	did	not	 find	any	positive	effects	of	ghrelin	administration	on	a	spatial-verbal	learning	task	(figure	2).	As	we	 injected	 ghrelin/placebo	 between	 two	 subsequent	 learning	 runs,	 we	 aimed	 to	differentiate	 between	 potential	 ghrelin	 effects	 on	 pure	 consolidation	 processes	 (first	run,	 before	 ghrelin	 application)	 and	 encoding	 processes	 (second	 run,	 after	 ghrelin	application).	 Given	 that	 previous	 findings	 show	 better	memory	 performance	 for	 food	versus	nonfood	 items	 in	physiological	 states	of	hunger118	 and	after	 ghrelin46,	we	used	food	 and	 non-food	 items	 as	 stimuli.	 In	 a	 repeated	 measures	 ANOVA	 comprising	 the	factors	 condition	 (ghrelin	 vs.	 placebo),	 time	 (consolidation	 vs.	 encoding)	 and	 stimulus	(food	 vs.	 non-food),	we	 observed	 no	 significant	main	 effect	 of	 condition	 on	 free	word	recall	 (F1,20=.356,	 p=.558,	 η2=.017),	 cued	 location-word	 association	 recall	 (F1,20=.014,	p=0.906,	η2=.001)	or	a	combined	score	comprising	all	words	remembered	in	both	free	and	 cued	 recall	 (F1,20=.271,	 p=.608,	 η2=.013).	 We	 further	 observed	 no	 significant	
condition	 ×	 time	 interaction,	 condition	 ×	 stimulus	 interaction,	 or	 condition	 ×	 time	 ×	
stimulus	 interaction	 for	any	of	 the	outcome	measures	 (all	F<1.08,	p>.311,	η2<.051;	see	figure	 2	 and	 supplemental	 table	 T1).	 Given	 our	 sample	 size	 and	 within-subject	correlations	 of	 test	 scores,	 medium-sized	 main	 effects	 of	 ghrelin	 and	 medium-sized	




related	brain	processing	for	food	words	as	compared	to	non-food	words	in	the	precuneus,	occipital	cortex	and	left	superior	frontal	gyrus	(see	supplemental	figure	S4).	However,	we	did	not	find	any	enhancing	or	modulating	effect	of	ghrelin	on	the	behavioral	or	neurobiological	effects	of	stimulus	type,	i.e.	food	vs.	non-food	items.		To	 test	 whether	 ghrelin	 modulated	 brain	 activation	 during	 rest,	 we	 first	performed	an	 independent	component	analysis	(ICA)	with	subsequent	dual	regression	on	the	fMRI	resting	state	data	in	order	to	search	for	ghrelin-induced	differences	in	large-scale	 functional	 brain	 networks.	 Setting	 the	 focus	 on	 memory-	 and	 appetite-related	changes,	 we	 restricted	 our	 analysis	 to	 the	 default	 mode	 network	 and	 the	 salience	network.	A	 comparison	of	 functional	 connectivity	within	 these	networks	did	not	 yield	any	significant	differences	between	conditions.		In	addition	to	the	ICA	dual	regression	approach,	we	also	performed	a	connectivity	analysis	of	the	fMRI	resting	state	data	between	the	following	regions	of	interest	(ROI)	of	each	 hemisphere	 based	 on	 previous	 literature46,68:	 hippocampus,	 amygdala,	orbitofrontal	cortex	(OFC),	insula,	caudate	nucleus,	and	nucleus	accumbens.	In	the	post-	as	 compared	 to	 pre-encoding	 resting	 state,	 we	 found	 a	 reduction	 of	 functional	connectivity	 of	 the	 bilateral	 caudate	 nucleus	 with	 the	 right	 orbitofrontal	 cortex	 and	bilateral	 insula,	 and	between	 the	 right	 caudate	 nucleus	 and	 the	 right	 amygdala	 under	ghrelin	compared	to	placebo	(all	pFDR<.05;	see	figure	3).	We	 did	 not	 detect	 any	 influence	 of	 ghrelin	 on	 other	 cognitive	 domains.	Performances	 in	 a	 working	 memory	 task	 (reverse	 digit	 span),	 a	 fluid	 reasoning	 test	(BOMAT	 matrices),	 a	 creativity	 task	 (alternative	 uses),	 a	 mental	 speed	 test	 (trail	making),	and	a	reaction	time	and	attention	task	(psychomotor	vigilance)	did	not	differ	significantly	 under	 the	 influence	 of	 ghrelin	 vs.	 placebo	 (all	 p>0.160;	 figure	 4).	 All	
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		Subsequent	memory	effect,	positive	contrast:	Voxels	 P	 Z	max	 Z-max	X	 Z-max	Y	 Z-max	Z	 Z-COG	X	 Z-COG	Y	 Z-COG	Z	1815	 3.57E-10	 3.71	 -40	 -50	 62	 -28.1	 -60.9	 52.7	817	 2.06E-05	 3.48	 -34	 -30	 -20	 -46.9	 -58.6	 -2.7	812	 2.20E-05	 3.95	 10	 10	 66	 -1.61	 11.6	 61.7	671	 0.000141	 3.4	 -28	 -2	 64	 -41.8	 4.76	 43.2	347	 0.0181	 3.48	 50	 -42	 -20	 47.5	 -50.1	 -11.8		Subsequent	memory	effect,	negative	contrast:	Voxels	 P	 Z	max	 Z-max	X	 Z-max	Y	 Z-max	Z	 Z-COG	X	 Z-COG	Y	 Z-COG	Z	803	 2.47E-05	 3.47	 54	 -60	 42	 50.6	 -59.6	 42.8	422	 0.00534	 3.82	 46	 46	 -8	 44.3	 49.5	 -4.82	346	 0.0184	 3.35	 14	 70	 18	 16.6	 62.5	 25.4	337	 0.0215	 3.62	 4	 -48	 22	 5.51	 -47	 26.9		Ghrelin	modulation	of	the	subsequent	memory	effect,	positive	contrast:	Voxels	 P	 Z	max	 Z-max	X	 Z-max	Y	 Z-max	Z	 Z-COG	X	 Z-COG	Y	 Z-COG	Z	
1824	 4.65E-10	 3.75	 20	 -88	 16	 15.9	 -72.1	 22.7	
611	 0.000381	 3.75	 -36	 -48	 70	 -37.7	 -49.6	 63.2	
442	 0.00446	 3.37	 -34	 -84	 16	 -31.1	 -80.3	 19.2		Ghrelin	modulation	of	the	subsequent	memory	effect,	negative	contrast:	Voxels	 P	 Z	max	 Z-max	X	 Z-max	Y	 Z-max	Z	 Z-COG	X	 Z-COG	Y	 Z-COG	Z	
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